Franklin Resources
CARM

Franklin Resources’s Carisma Therapeutics CARM Stock Holding History

Franklin Resources’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-115,729
Closed -$6.97M – 1518
2015
Q4 		$6.97M Buy
115,729
+19,869
+21% +$1.13M ﹤0.01% 1073
2015
Q3 		$4.62M Buy
95,860
+9,920
+12% +$611K ﹤0.01% 1161
2015
Q2 		$4.85M Buy
85,940
+39,445
+85% +$5.57M ﹤0.01% 1181
2015
Q1 		$8.29M Buy
46,495
+5,985
+15% +$1.31M ﹤0.01% 1087
2014
Q4 		$9.63M Sell
40,510
-249
-0.6% -$55.8K ﹤0.01% 1054
2014
Q3 		$9.08M Sell
40,759
-10,621
-21% -$2.52M ﹤0.01% 1060
2014
Q2 		$13.5M Buy
51,380
+4,475
+10% +$1.11M 0.01% 981
2014
Q1 		$15.2M Buy
+46,905
New +$14M 0.01% 923

Other funds holding CARM

FVF2
Flagship Ventures Fund 2007 Cambridge, Massachusetts $95.2M AUM
FVFI
Flagship Ventures Fund IV Cambridge, Massachusetts $382M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources's CARM Position: Q1 2016 in Review

Franklin Resources sold out of Carisma Therapeutics (CARM) in Q1 2016, closing a stake of 115,729 shares — an estimated $6.97M sold.

Franklin Resources first reported a position in CARM in Q1 2014 and held it in 8 quarters. The position peaked at $15.2M in Q1 2014. 23 funds tracked by Wall St. Rank hold CARM as of Q1 2016.

  • Franklin Resources reported no remaining Carisma Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Franklin Resources sold 115,729 Carisma Therapeutics shares in Q1 2016, an estimated $6.97M.
  • Franklin Resources first reported a position in Carisma Therapeutics in Q1 2014 and held it in 8 quarters.
  • Franklin Resources's Carisma Therapeutics position peaked at $15.2M in Q1 2014.
  • 23 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2016.

Based on Franklin Resources's 13F filing for Q1 2016, filed 10 May 2016.